Cargando…
Structure-based drug discovery for combating influenza virus by targeting the PA–PB1 interaction
Influenza virus infections are serious public health concerns throughout the world. The development of compounds with novel mechanisms of action is urgently required due to the emergence of viruses with resistance to the currently-approved anti-influenza viral drugs. We performed in silico screening...
Autores principales: | Watanabe, Ken, Ishikawa, Takeshi, Otaki, Hiroki, Mizuta, Satoshi, Hamada, Tsuyoshi, Nakagaki, Takehiro, Ishibashi, Daisuke, Urata, Shuzo, Yasuda, Jiro, Tanaka, Yoshimasa, Nishida, Noriyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5573363/ https://www.ncbi.nlm.nih.gov/pubmed/28842649 http://dx.doi.org/10.1038/s41598-017-10021-w |
Ejemplares similares
-
Structure-Based Drug Discovery for Prion Disease Using a Novel Binding Simulation
por: Ishibashi, Daisuke, et al.
Publicado: (2016) -
Liquid–liquid phase separation of full-length prion protein initiates conformational conversion in vitro
por: Tange, Hiroya, et al.
Publicado: (2021) -
Ubiquitin-specific protease 14 modulates degradation of cellular prion protein
por: Homma, Takujiro, et al.
Publicado: (2015) -
Type I interferon protects neurons from prions in in vivo models
por: Ishibashi, Daisuke, et al.
Publicado: (2019) -
Molecular Mechanism of Arenavirus Assembly and Budding
por: Urata, Shuzo, et al.
Publicado: (2012)